Swiss giants Roche to buy US gene therapy group Spark for $4.3 billion

[BECKHAM]

Swiss pharmaceutical giant Roche has announced that it has reached a $4.3 billion deal to acquire Spark Therapeutics, a US group specializing in the development of gene therapy drugs.

for more... (https://www.thelocal.ch/20190225/swiss-giants-roche-to-buy-us-gene-therapy-group-spark-for-43-billion)